XRTXInvestor Event•globenewswire•
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
Sentiment:Negative (20)
Summary
(NASDAQ:XRTX) CALGARY, Alberta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to invite investors to a webinar and Q&A session on September 10, 2025, at 4:15 pm ET.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 4, 2025 by globenewswire